Yes, Aurora kinases have emerged as promising therapeutic targets for cancer treatment. Several small-molecule inhibitors targeting Aurora kinases have been developed and are currently in various stages of clinical trials. These inhibitors aim to disrupt the kinase activity, thereby impeding cancer cell proliferation and inducing cell death.
